What is the Kuschnir Classification for Chagas Disease?
At a Glance
The Kuschnir classification stages Chagas heart disease from 0 to 3 based on electrical activity, heart size, and heart failure symptoms. It helps doctors assess heart involvement to guide treatment. About 60-70% of patients stay in Stage 0 and never develop heart problems.
In this answer
2 sections
When you have Chagas disease (also known as American trypanosomiasis), doctors need a clear way to understand if and how the condition is affecting your heart [1]. To do this, they often use a tool called the Kuschnir classification system [1]. This staging system helps your care team measure the level of heart involvement, track changes over time, and determine the best ways to monitor and protect your health [2][3]. It categorizes Chagas heart disease (cardiomyopathy) into four distinct stages based on three main factors: the electrical activity in your heart, the physical size of your heart, and whether you are experiencing symptoms of heart failure [1].
To figure out your stage, your doctor will look at the results of an electrocardiogram (ECG) (a test that measures your heart’s electrical signals), a chest X-ray or echocardiogram (an ultrasound of the heart to look at its size and pumping ability), and a physical exam to check for symptoms [1][2].
(Note: While doctors commonly use the Kuschnir system, they sometimes refer to these stages as “Groups,” or they may use other staging systems, like the Latin American Consensus “ABCD” staging [2][1]. If your doctor uses different letters or numbers, it is simply a different way to measure the same three factors.)
The Four Stages of the Kuschnir Classification
Stage 0
Stage 0 is often referred to as the “indeterminate” form of Chagas disease [4]. At this stage, blood tests show that you have the Trypanosoma cruzi parasite that causes Chagas, but there is no evidence of heart involvement [5][1]. Both your ECG and your heart imaging tests (X-ray or echocardiogram) are completely normal, meaning the heart’s electrical system and structure are working exactly as they should [1][4]. You will not have any heart-related symptoms [5].
Importantly, being diagnosed with Chagas disease does not mean heart failure is inevitable. In fact, approximately 60% to 70% of people with Chagas disease will remain in Stage 0 for their entire lives and will never develop heart problems [6].
Stage I
In Stage I, there is early evidence that the disease has started to affect the heart’s electrical system [1][7]. Your doctor may notice characteristic abnormalities on your ECG, such as a Right Bundle Branch Block (RBBB) or Left Anterior Fascicular Block (LAFB) [7][8]. These terms simply mean there is a delay or blockage in the electrical pathways that tell your heart muscles when to squeeze [9]. Despite these electrical changes, the heart is still a normal size, and you will not have any clinical symptoms of heart failure [1][8].
Stage II
If the disease progresses to Stage II, the ECG abnormalities are still present, but imaging tests will now show cardiomegaly [1][7]. Cardiomegaly means that the heart has become dilated, stretched, or enlarged [7]. However, even with these changes to the heart’s electrical system and size, individuals in Stage II do not experience clinical signs or symptoms of heart failure [1].
Stage III
Stage III is the most advanced stage of the Kuschnir classification [4]. At this point, the ECG shows electrical abnormalities, the heart is enlarged (cardiomegaly), and you are experiencing clinical symptoms of heart failure [1][4]. Heart failure means the heart isn’t pumping blood as well as it should be, which can cause symptoms like shortness of breath, severe fatigue, or swelling in the legs and ankles.
Why Staging Empowers Your Care
Knowing your Kuschnir stage helps your medical team proactively protect your heart. While the condition can progress and increase the risk of complications—such as irregular heart rhythms (arrhythmias) or blood clots (thromboembolic events)—identifying your exact stage gives you and your doctor a roadmap for action [1][10][11].
For example, if you are in early stages, your doctor can establish a routine timeline for monitoring (like an annual ECG) to catch any changes early [2]. If you are in a later stage, your care team can introduce specialized medications to support the heart’s pumping ability, prescribe treatments to manage irregular rhythms, and help you make lifestyle adjustments to feel better and slow disease progression [12][1]. Staging ensures you get the exact level of care you need when you need it [3].
Common questions in this guide
What is the Kuschnir classification system?
Does having Chagas disease mean I will definitely get heart failure?
What does Stage 1 Chagas heart disease mean?
What is the difference between Stage II and Stage III Chagas disease?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What Kuschnir stage or clinical group is my heart condition currently in?
- 2.Based on my current stage, how often should I be getting an ECG or an echocardiogram to monitor for changes?
- 3.Are there any medications or lifestyle changes I should start right now to help protect my heart from progressing to a later stage?
- 4.If my chart mentions a different staging system, like the ABCD system, how does that translate to the electrical and physical health of my heart?
- 5.If my ECG shows an electrical block, what specific symptoms should I watch out for at home that would mean I need to call you?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care.
Saraiva RM, Mediano MFF, Mendes FS, et al.
World journal of cardiology 2021; (13(12)):654-675 doi:10.4330/wjc.v13.i12.654.
PMID: 35070110 - 2
Chagas Cardiomyopathy: Usefulness of EKG and Echocardiogram in a Non-Endemic Country.
Sánchez-Montalvá A, Salvador F, Rodríguez-Palomares J, et al.
PloS one 2016; (11(6)):e0157597 doi:10.1371/journal.pone.0157597.
PMID: 27308824 - 3
Diagnosis and management of chagasic cardiomyopathy patients in several institutions in Argentina.
Chuit R, Antonietti L, Agüero RN, et al.
Frontiers in parasitology 2023; (2()):1195646 doi:10.3389/fpara.2023.1195646.
PMID: 39816819 - 4
Stroke in Chagas disease: from pathophysiology to clinical practice.
Lage TAR, Tupinambás JT, Pádua LB, et al.
Revista da Sociedade Brasileira de Medicina Tropical 2022; (55()):e0575 doi:10.1590/0037-8682-0575-2021.
PMID: 35674560 - 5
Electrocardiogram in Chagas disease.
Brito BOF, Ribeiro ALP
Revista da Sociedade Brasileira de Medicina Tropical 2018; (51(5)):570-577 doi:10.1590/0037-8682-0184-2018.
PMID: 30304260 - 6
Updated review on the pathophysiology of Chagas cardiomyopathy.
Pech-Aguilar AG, Haro-Álvarez AP, Rosado-Vallado ME
Revista medica del Instituto Mexicano del Seguro Social 2020; (58(3)):328-334 doi:10.24875/RMIMSS.M20000037.
PMID: 34002992 - 7
Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.
Fernandez AB, Nunes MC, Clark EH, et al.
Global heart 2015; (10(3)):159-66.
PMID: 26407511 - 8
The Prevalence of Atrial Fibrillation and Conduction Abnormalities in Chagas' Disease: A Meta-Analysis.
Cardoso R, Garcia D, Fernandes G, et al.
Journal of cardiovascular electrophysiology 2016; (27(2)):161-9 doi:10.1111/jce.12845.
PMID: 26412204 - 9
Deriving a parsimonious cardiac endpoint for use in epidemiological studies of Chagas disease: results from the Retrovirus Epidemiology Donor Study-II (REDS-II) cohort.
Buss LF, Bes TM, Pereira A, et al.
Revista do Instituto de Medicina Tropical de Sao Paulo 2021; (63()):e31 doi:10.1590/S1678-9946202163031.
PMID: 33909845 - 10
Clinical features of Chagas disease progression and severity.
Nunes MCP, Bern C, Clark EH, et al.
Lancet regional health. Americas 2024; (37()):100832 doi:10.1016/j.lana.2024.100832.
PMID: 39474468 - 11
Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three-headed monster.
Echeverría LE, Serrano-García AY, Rojas LZ, et al.
European journal of heart failure 2024; (26(12)):2502-2514 doi:10.1002/ejhf.3460.
PMID: 39327798 - 12
The expression of immune response genes in patients with chronic Chagas disease is shifted toward the levels observed in healthy subjects as a result of treatment with Benznidazole.
Gómez I, Egui A, Palacios G, et al.
Frontiers in cellular and infection microbiology 2024; (14()):1439714 doi:10.3389/fcimb.2024.1439714.
PMID: 39119291
This page explains the Kuschnir classification system for educational purposes only. Always consult your cardiologist or infectious disease specialist for specific interpretations of your Chagas disease stage and test results.
Get notified when new evidence is published on American trypanosomiasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.